{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:17:08Z","timestamp":1788797828343,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,7,20]],"date-time":"2013-07-20T00:00:00Z","timestamp":1374278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s40256-013-0038-z","type":"journal-article","created":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T03:36:19Z","timestamp":1374204979000},"page":"407-412","source":"Crossref","is-referenced-by-count":8,"title":["Impact of Ranolazine on Clinical Outcomes and Healthcare Resource Utilization in Patients with Refractory Angina Pectoris"],"prefix":"10.1007","volume":"13","author":[{"given":"Hua","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"Packard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy L.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Hilleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,20]]},"reference":[{"key":"38_CR1","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1161\/CIR.0b013e31828124ad","volume":"127","author":"AS Go","year":"2013","unstructured":"Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics\u20142013 update: a report from the American Heart Association. Circulation. 2013;127:e6\u2013245.","journal-title":"Circulation"},{"key":"38_CR2","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.cjca.2011.07.007","volume":"28","author":"M McGillion","year":"2012","unstructured":"McGillion M, Arthur HM, Cook A, et al. Management of patients with refractory angina: Canadian Cardiovascular Society\/Canadian Pain Society Joint Guidelines. Can J Cardiol. 2012;28:S20\u201341.","journal-title":"Can J Cardiol"},{"key":"38_CR3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.hco.0000240588.22086.43","volume":"21","author":"AB Bhatt","year":"2006","unstructured":"Bhatt AB, Stone PH. Current strategies for the prevention of angina in patients with stable coronary artery disease. Curr Opin Cardiol. 2006;21:492\u2013502.","journal-title":"Curr Opin Cardiol"},{"key":"38_CR4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11936-009-0006-8","volume":"11","author":"O Soran","year":"2009","unstructured":"Soran O. Treatment options for refractory angina pectoris: enhanced external counterpulsation therapy. Curr Treat Options Cardiovasc Med. 2009;11:54\u201360.","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"38_CR5","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0735-1097(02)01716-3","volume":"39","author":"MC Kim","year":"2002","unstructured":"Kim MC, Kini A, Sharma S. Refractory angina pectoris: mechanism and therapeutic options. J Am Coll Cardiol. 2002;39:923\u201334.","journal-title":"J Am Coll Cardiol"},{"key":"38_CR6","doi-asserted-by":"crossref","unstructured":"Stewart S, Murphy N, Walker A. McGuire A, McMurray JJV. The current cost of angina pectoris to the National Health Service in the UK. Heart. 2003; 89:848\u201353.","DOI":"10.1136\/heart.89.8.848"},{"key":"38_CR7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0828-282X(08)70680-9","volume":"24","author":"M McGillion","year":"2008","unstructured":"McGillion M, Croxford R, Watt-Watson J, Stevens B, LeFort S, Coyte P. Cost of illness for chronic angina pectoris patients enrolled in a self management education trial. Can J Cardiol. 2008;24:759\u201364.","journal-title":"Can J Cardiol"},{"key":"38_CR8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2147\/TCRM.S4468","volume":"6","author":"D Vadnais","year":"2010","unstructured":"Vadnais D, Wenger NK. Emerging clinical role of ranolazine in the management of angina. Ther Clin Risk Mgt. 2010;6:517\u201330.","journal-title":"Ther Clin Risk Mgt"},{"key":"38_CR9","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jacc.2010.04.042","volume":"56","author":"PH Stone","year":"2010","unstructured":"Stone PH, Chaitman BR, Stocke K, Sano J, DeVault A, Koch GG. The anti-ischemic mechanism of action of ranolazine in stable ischemic heart disease. J Am Coll Cardiol. 2010;56:934\u201342.","journal-title":"J Am Coll Cardiol"},{"key":"38_CR10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40256-012-0003-2","volume":"13","author":"N Hawwa","year":"2013","unstructured":"Hawwa N, Menon V. Ranolazine: clinical applications and therapeutic basis. Am J Cardiovasc Drugs. 2013;13:5\u201316.","journal-title":"Am J Cardiovasc Drugs"},{"key":"38_CR11","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2003.11.045","volume":"43","author":"BR Chaitman","year":"2004","unstructured":"Chaitman BR, Skettino SL, Parker JO, et al. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. J Am Coll Cardiol. 2004;43:1375\u201382.","journal-title":"J Am Coll Cardiol"},{"key":"38_CR12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","volume":"291","author":"BR Chaitman","year":"2004","unstructured":"Chaitman BR, Pepine CJ, Parker CO, et al. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. JAMA. 2004;291:309\u201316.","journal-title":"JAMA"},{"key":"38_CR13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","volume":"48","author":"PH Stone","year":"2006","unstructured":"Stone PH, Gratsiansky NA, Blokhin A, Huang IZ, Meng L. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina Trial). J Am Coll Cardiol. 2006;48:566\u201375.","journal-title":"J Am Coll Cardiol"},{"key":"38_CR14","doi-asserted-by":"crossref","unstructured":"Greene RS, Rangel RM, Edwards KL, et al. Ranolazine for the treatment of refractory angina in a veterans population. Cardiovasc Revasc Med. 2012;13(2):141.e1-5.","DOI":"10.1016\/j.carrev.2011.06.001"},{"key":"38_CR15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1345\/aph.1Q487","volume":"46","author":"DN Reeder","year":"2012","unstructured":"Reeder DN, Gilette MA, Franck AJ, Frohnapple DJ. Clinical experience with ranolazine in a veteran population with chronic stable angina. Ann Pharmacotherapy. 2012;46:42\u201350.","journal-title":"Ann Pharmacotherapy"},{"key":"38_CR16","doi-asserted-by":"crossref","unstructured":"Bennett NM, Arndt TL, Iyer V, et al. Ranolazine refractory angina registry trial: 1\u00a0year results. J Am Coll Cardiol. 2011; 57: E1050 (abstract).","DOI":"10.1016\/S0735-1097(11)61050-4"},{"key":"38_CR17","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.clinthera.2012.04.025","volume":"34","author":"CE Phelps","year":"2012","unstructured":"Phelps CE, Buysman EK. Gomez Ray G. Costs and clinical outcomes associated with the use of ranolazine for treatment of angina. Clin Ther. 2012;34:1395\u2013407.","journal-title":"Clin Ther"},{"key":"38_CR18","unstructured":"Gilead Sciences. Ranolazine for incomplete vessel revascularization post-percutaneous coronary intervention (PCI) (RIVER-PCI). Available from: http:\/\/clinicaltrials.gov\/show\/NCT01442038 . Accessed 16 July 2013."}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-013-0038-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40256-013-0038-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-013-0038-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T18:07:00Z","timestamp":1563473220000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40256-013-0038-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,20]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["38"],"URL":"https:\/\/doi.org\/10.1007\/s40256-013-0038-z","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,20]]}}}